Terms: = Pancreatic cancer AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Diagnosis
13 results:
1. Glucagon-Like Peptide-1 Receptor Agonists and pancreatic cancer Risk in Patients With Type 2 Diabetes.
Dankner R; Murad H; Agay N; Olmer L; Freedman LS
JAMA Netw Open; 2024 Jan; 7(1):e2350408. PubMed ID: 38175642
[TBL] [Abstract] [Full Text] [Related]
2. Integrated Genomic and Clinicopathologic Approach Distinguishes pancreatic Grade 3 Neuroendocrine Tumor From Neuroendocrine Carcinoma and Identifies a Subset With Molecular Overlap.
Umetsu SE; Kakar S; Basturk O; Kim GE; Chatterjee D; Wen KW; Hale G; Shafizadeh N; Cho SJ; Whitman J; Gill RM; Jones KD; Navale P; Bergsland E; Klimstra D; Joseph NM
Mod Pathol; 2023 Mar; 36(3):100065. PubMed ID: 36788102
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence, features, and explanations of missed and misinterpreted pancreatic cancer on imaging: a matched case-control study.
Hoogenboom SA; Engels MML; Chuprin AV; van Hooft JE; LeGout JD; Wallace MB; Bolan CW
Abdom Radiol (NY); 2022 Dec; 47(12):4160-4172. PubMed ID: 36127473
[TBL] [Abstract] [Full Text] [Related]
4. Extra-appendicular neuroendocrine tumors: A report from the TREP project (2000-2020).
Virgone C; Ferrari A; Chiaravalli S; De Pasquale MD; Inserra A; D'Angelo P; Ogunleye MF; Crocoli A; Vallero S; Cesaro S; Alaggio R; Bisogno G; Dall'Igna P
Pediatr Blood Cancer; 2021 Apr; 68(4):e28880. PubMed ID: 33522705
[TBL] [Abstract] [Full Text] [Related]
5. pancreatic resections in patients who refuse blood transfusions. The application of a perioperative protocol for a true bloodless surgery.
De Bellis M; Girelli D; Ruzzenente A; Bagante F; Ziello R; Campagnaro T; Conci S; Nifosì F; Guglielmi A; Iacono C
Pancreatology; 2020 Oct; 20(7):1550-1557. PubMed ID: 32950387
[TBL] [Abstract] [Full Text] [Related]
6. Hepatic angiomyolipoma: an international multicenter analysis on diagnosis, management and outcome.
Klompenhouwer AJ; Dwarkasing RS; Doukas M; Pellegrino S; Vilgrain V; Paradis V; Soubrane O; Beane JD; Geller DA; Nalesnik MA; Tripke V; Lang H; Schmelzle M; Pratschke J; Schöning W; Beal E; Sun S; Pawlik TM; de Man RA; Ijzermans JNM
HPB (Oxford); 2020 Apr; 22(4):622-629. PubMed ID: 31619346
[TBL] [Abstract] [Full Text] [Related]
7. Integrated analysis of gene expression and copy number variations in MET proto‑oncogene‑transformed human primary osteoblasts.
Jia RJ; Lan CG; Wang XC; Gao CT
Mol Med Rep; 2018 Feb; 17(2):2543-2548. PubMed ID: 29207108
[TBL] [Abstract] [Full Text] [Related]
8. Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies.
Pang Y; Kartsonaki C; Guo Y; Bragg F; Yang L; Bian Z; Chen Y; Iona A; Millwood IY; Lv J; Yu C; Chen J; Li L; Holmes MV; Chen Z
Int J Cancer; 2017 Apr; 140(8):1781-1788. PubMed ID: 28063165
[TBL] [Abstract] [Full Text] [Related]
9. cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.
Dey D; Kenu E; Isenberg DA
Lupus; 2013 Aug; 22(9):919-27. PubMed ID: 23857987
[TBL] [Abstract] [Full Text] [Related]
10. The predictive value of mean platelet volume in differential diagnosis of non-functional pancreatic neuroendocrine tumors from pancreatic adenocarcinomas.
Karaman K; Bostanci EB; Aksoy E; Kurt M; Celep B; Ulas M; Dalgic T; Surmelioglu A; Hayran M; Akoglu M
Eur J Intern Med; 2011 Dec; 22(6):e95-8. PubMed ID: 22075321
[TBL] [Abstract] [Full Text] [Related]
11. Cell block technique and cytological smears for the differential diagnosis of pancreatic neoplasms after endosonography-guided fine-needle aspiration.
Ardengh JC; Lopes CV; de Lima LF; Venco F; Santo GC; Begnami MD; Módena JL
Acta Gastroenterol Latinoam; 2008 Dec; 38(4):246-51. PubMed ID: 19157379
[TBL] [Abstract] [Full Text] [Related]
12. diagnosis of pancreatic tumors by endoscopic ultrasound-guided fine-needle aspiration.
Ardengh JC; Lopes CV; de Lima LF; de Oliveira JR; Venco F; Santo GC; Modena JL
World J Gastroenterol; 2007 Jun; 13(22):3112-6. PubMed ID: 17589929
[TBL] [Abstract] [Full Text] [Related]
13. External imaging of ccnd1, MYC, and KRAS oncogene mRNAs with tumor-targeted radionuclide-PNA-peptide chimeras.
Tian X; Chakrabarti A; Amirkhanov NV; Aruva MR; Zhang K; Mathew B; Cardi C; Qin W; Sauter ER; Thakur ML; Wickstrom E
Ann N Y Acad Sci; 2005 Nov; 1059():106-44. PubMed ID: 16382049
[TBL] [Abstract] [Full Text] [Related]
